Skip to main content
Erschienen in: International Journal of Diabetes in Developing Countries 2/2017

18.03.2015 | Original Article

Lipid peroxidation, antioxidants, lipid profile, and HbA1c in diabetic patients

verfasst von: Chhunthang Thanpari, Roshan Takhelmayum, Naval Kishor Yadav, Mukesh Kumar Shrewastwa, Priyanka Thapa, Ravindra Kumar Mittal

Erschienen in: International Journal of Diabetes in Developing Countries | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Diabetes mellitus is characterized by hyperglycemia together with biochemical changes in glucose, lipid profile, lipid peroxidation, and antioxidants status. This study aims to assess lipid profile, lipid peroxidation, antioxidants, and glycated hemoglobin (HbA1c) in type 1 and type 2 diabetic subjects. Type 1 and type 2 diabetic patients were selected from the subjects attending OPD in Nepalgunj Medical College, Nepal, for medical checkup. Fasting blood sugar (FBS), lipid profile, lipid peroxidation (malondialdehyde), and antioxidants status (reduced glutathione and vitamin E) were estimated in both groups and were compared with healthy controls. Low-density lipoprotein (LDL)/high-density lipoprotein (HDL) ratio was calculated to assess the cardiovascular risk factors. When type 1 diabetic patients were compared with type 2 diabetic patients, it showed statistically significant increase in the levels of HbA1c, triglycerides (TGs), and high-density lipoprotein cholesterol (HDL-C), whereas statistically significant decreased level was found in malondialdehyde (MDA). FBS, total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), reduced glutathione (GSH), vitamin E, and HDL/LDL ratio were not significant. Early diagnosis of dyslipidemia and oxidative stress can be used as a preventive measure for the development of microvascular and macrovascular complications in type 1 and type 2 diabetes mellitus.
Literatur
1.
Zurück zum Zitat Wild S, Bchir MB, Roglic P, et al. Global prevalence of diabetes. Estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–53.CrossRefPubMed Wild S, Bchir MB, Roglic P, et al. Global prevalence of diabetes. Estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–53.CrossRefPubMed
2.
Zurück zum Zitat Gabby KH, Sosenko JM, Banuchi GA, Minin MJ, Fluckigu R. Glycosylated hemoglobins; increased glycosylation of haemoglobin A in diabetes patients. Diabetes. 1979;28(4):337–40.CrossRef Gabby KH, Sosenko JM, Banuchi GA, Minin MJ, Fluckigu R. Glycosylated hemoglobins; increased glycosylation of haemoglobin A in diabetes patients. Diabetes. 1979;28(4):337–40.CrossRef
3.
Zurück zum Zitat Vasudevan DM, Sreekumari S, Vaidyanathan K. Textbook of biochemistry for medical students. 6th ed. New Delhi: JaypeeBrothers; 2010. Vasudevan DM, Sreekumari S, Vaidyanathan K. Textbook of biochemistry for medical students. 6th ed. New Delhi: JaypeeBrothers; 2010.
4.
Zurück zum Zitat American Diabetes association. Management of dyslipidaemia in adults with diabetes. Diabetes Care. 1998;21(supp l):36–9.CrossRef American Diabetes association. Management of dyslipidaemia in adults with diabetes. Diabetes Care. 1998;21(supp l):36–9.CrossRef
5.
Zurück zum Zitat Mahreen R, Mohsin M, Nasreen Z, Siraj M, Ishaq M. Significantly increased levels of serum malondialdehyde in type 2 diabetics with myocardial infarction. Int J Diabetes DevCtries. 2010;30:49–51.CrossRef Mahreen R, Mohsin M, Nasreen Z, Siraj M, Ishaq M. Significantly increased levels of serum malondialdehyde in type 2 diabetics with myocardial infarction. Int J Diabetes DevCtries. 2010;30:49–51.CrossRef
6.
Zurück zum Zitat Liu SX, Hou FF, Guo ZJ, Ryoji N, Ru ZW, Qiang LZ, et al. Advanced oxidation protein products accelerate atherosclerosis through promoting oxidative stress and inflammation. Arterioscler Thromb Vasc Biol. 2006;26:1156–62.CrossRefPubMed Liu SX, Hou FF, Guo ZJ, Ryoji N, Ru ZW, Qiang LZ, et al. Advanced oxidation protein products accelerate atherosclerosis through promoting oxidative stress and inflammation. Arterioscler Thromb Vasc Biol. 2006;26:1156–62.CrossRefPubMed
7.
Zurück zum Zitat Bradley AA, Nathan CF. Glutathione metabolism as a determinant of therapeutic efficiency. Cancer Res. 1984;44(10):4224–32. Bradley AA, Nathan CF. Glutathione metabolism as a determinant of therapeutic efficiency. Cancer Res. 1984;44(10):4224–32.
8.
Zurück zum Zitat Polidori MC, Mecocci P, Stahl W, Parente B, Cecchetti R, Cherubini A, et al. Plasma levels of lipophilic antioxidants in very old patients with type 2 diabetes. Diabetes Metab Res Rev. 2000;16(1):15–9.CrossRefPubMed Polidori MC, Mecocci P, Stahl W, Parente B, Cecchetti R, Cherubini A, et al. Plasma levels of lipophilic antioxidants in very old patients with type 2 diabetes. Diabetes Metab Res Rev. 2000;16(1):15–9.CrossRefPubMed
9.
Zurück zum Zitat Baynes JW, Thorpe SR. The role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes. 1999;48(1):1–9.CrossRefPubMed Baynes JW, Thorpe SR. The role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes. 1999;48(1):1–9.CrossRefPubMed
10.
11.
Zurück zum Zitat Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499–502.PubMed Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499–502.PubMed
12.
13.
Zurück zum Zitat Bieri JG, Teets L, Belavady B, Andrews EL. Serum vitamin E levels in a normal adult population in the Washington DC area. Proc Soc Exp Med. 1964;117:131–3.CrossRef Bieri JG, Teets L, Belavady B, Andrews EL. Serum vitamin E levels in a normal adult population in the Washington DC area. Proc Soc Exp Med. 1964;117:131–3.CrossRef
14.
Zurück zum Zitat Beutler E, Duron O, Kelly BM. Improved method for the determination of blood glutathione. J Lab Clin Med. 1963;61:882–8.PubMed Beutler E, Duron O, Kelly BM. Improved method for the determination of blood glutathione. J Lab Clin Med. 1963;61:882–8.PubMed
15.
Zurück zum Zitat Grundy SM. Hypertriglyceridemia, insulin resistance, and the metabolic syndrome. Am J Cardiol. 1999; 83(9) supplement 2: 25F-29F. Grundy SM. Hypertriglyceridemia, insulin resistance, and the metabolic syndrome. Am J Cardiol. 1999; 83(9) supplement 2: 25F-29F.
16.
Zurück zum Zitat Nikkila EA, Hormila P. Serum lipids and lipoproteins in insulin-treated diabetes. Demonstration of increased high density lipoprotein concentrations. Diabetes. 1978;27(11):1078–86.CrossRefPubMed Nikkila EA, Hormila P. Serum lipids and lipoproteins in insulin-treated diabetes. Demonstration of increased high density lipoprotein concentrations. Diabetes. 1978;27(11):1078–86.CrossRefPubMed
17.
Zurück zum Zitat Maharjan BR, Jha JC, Adhikari D, Vishwanath P, Baxi J, Alukar VM, et al. A study of oxidative stress, antioxidant status and lipid profile in diabetic patient in the western region of Nepal. Kathmandu Univ Med J. 2008;6(1):16–22. Maharjan BR, Jha JC, Adhikari D, Vishwanath P, Baxi J, Alukar VM, et al. A study of oxidative stress, antioxidant status and lipid profile in diabetic patient in the western region of Nepal. Kathmandu Univ Med J. 2008;6(1):16–22.
18.
Zurück zum Zitat Aleyassine H, Gardiner RJ, Tonks PB, Koch P. Glycosylated hemoglobin in diabetes mellitus: correlations with fasting plasma glucose, serum lipids, and glycosuria. Diabetes Care. 1980;3(4):508–14.CrossRefPubMed Aleyassine H, Gardiner RJ, Tonks PB, Koch P. Glycosylated hemoglobin in diabetes mellitus: correlations with fasting plasma glucose, serum lipids, and glycosuria. Diabetes Care. 1980;3(4):508–14.CrossRefPubMed
19.
Zurück zum Zitat Bitzur R, Cohen H, Kumari Y, et al. Triglycerides and HDL cholesterol. Diabetes Care. 2009;3 Suppl 2:373–7.CrossRef Bitzur R, Cohen H, Kumari Y, et al. Triglycerides and HDL cholesterol. Diabetes Care. 2009;3 Suppl 2:373–7.CrossRef
20.
Zurück zum Zitat Masram SW, Bimanpalli MV, Suresh G. Study of lipid profile and glycated hemoglobin in diabetes mellitus. Indian Med Gaz. 2012;7:257–65. Masram SW, Bimanpalli MV, Suresh G. Study of lipid profile and glycated hemoglobin in diabetes mellitus. Indian Med Gaz. 2012;7:257–65.
21.
Zurück zum Zitat McEneny J, O’Kane MJ, Moles KW, McMaster D, Mercer C. Very low density lipoprotein subfractions in type II diabetes mellitus: alterations in composition and susceptibility to oxidation. Diabetologia. 2000;43(4):485–93.CrossRefPubMed McEneny J, O’Kane MJ, Moles KW, McMaster D, Mercer C. Very low density lipoprotein subfractions in type II diabetes mellitus: alterations in composition and susceptibility to oxidation. Diabetologia. 2000;43(4):485–93.CrossRefPubMed
22.
Zurück zum Zitat Nita G, Agarwal YB, Gupta S. A study of lipid profile levels in diabetics and nondiabetics taking TC/HDL and LDL/HDL ratio into consideration. J Indian Acad Clin Med. 2014;15(3 and 4):192–5. Nita G, Agarwal YB, Gupta S. A study of lipid profile levels in diabetics and nondiabetics taking TC/HDL and LDL/HDL ratio into consideration. J Indian Acad Clin Med. 2014;15(3 and 4):192–5.
23.
Zurück zum Zitat Singh M, Shin S. Changes in erythrocyte aggregation and deformability in diabetes mellitus: a brief review. Indian J Exp Biol. 2009;47(1):7–15.PubMed Singh M, Shin S. Changes in erythrocyte aggregation and deformability in diabetes mellitus: a brief review. Indian J Exp Biol. 2009;47(1):7–15.PubMed
24.
Zurück zum Zitat Nacítarhan S, Ozben T, Tuncer N. Serum and urine malondialdehyde levels in NIDDM patients with and without hyperlipidaemia. Free Radic Biol Med. 1995;19(6):893–6.CrossRefPubMed Nacítarhan S, Ozben T, Tuncer N. Serum and urine malondialdehyde levels in NIDDM patients with and without hyperlipidaemia. Free Radic Biol Med. 1995;19(6):893–6.CrossRefPubMed
25.
Zurück zum Zitat Velazquez E, Winocour PH, Kesteven P, Alberti KG, Laker MF. Relation of lipid peroxides to macrovascular disease in type 2 diabetes. Diabet Med. 1991;8(8):752–8.CrossRefPubMed Velazquez E, Winocour PH, Kesteven P, Alberti KG, Laker MF. Relation of lipid peroxides to macrovascular disease in type 2 diabetes. Diabet Med. 1991;8(8):752–8.CrossRefPubMed
26.
Zurück zum Zitat Giugliano D, Ceriello A, Paolisso G. Diabetes mellitus, hypertension, and cardiovascular disease: which role for oxidative stress? Metabolism. 1995;44(3):363–8.CrossRefPubMed Giugliano D, Ceriello A, Paolisso G. Diabetes mellitus, hypertension, and cardiovascular disease: which role for oxidative stress? Metabolism. 1995;44(3):363–8.CrossRefPubMed
27.
Zurück zum Zitat Ceriello A, Bortolotti N, Pirisi M, Crescentini A, Tonutti L, Motz E, et al. Total plasma antioxidant capacity predicts thrombosis-prone status in NIDDM patients. Diabetes Care. 1997;20(10):1589–93.CrossRefPubMed Ceriello A, Bortolotti N, Pirisi M, Crescentini A, Tonutti L, Motz E, et al. Total plasma antioxidant capacity predicts thrombosis-prone status in NIDDM patients. Diabetes Care. 1997;20(10):1589–93.CrossRefPubMed
28.
Zurück zum Zitat Weber G, Convery HJ. Insulin: inducer of glucose-6-phosphate dehydrogenase. Life Sci. 1966;5(12):1139–46.CrossRefPubMed Weber G, Convery HJ. Insulin: inducer of glucose-6-phosphate dehydrogenase. Life Sci. 1966;5(12):1139–46.CrossRefPubMed
29.
Zurück zum Zitat Dincer Y, Alademir Z, Ilkova H, Akcay T. Susceptibility of glutathione and glutathione-related antioxidant activity to hydrogen peroxide in patients with type 2 diabetes: effect of glycemic control. Clin Biochem. 2002;35(4):297–301.CrossRefPubMed Dincer Y, Alademir Z, Ilkova H, Akcay T. Susceptibility of glutathione and glutathione-related antioxidant activity to hydrogen peroxide in patients with type 2 diabetes: effect of glycemic control. Clin Biochem. 2002;35(4):297–301.CrossRefPubMed
30.
Zurück zum Zitat Ceriello A, Bortolotti N, Crescentini A, Motz E, Lizzio S, Russo A, et al. Antioxidant defences are reduced during the oral glucose tolerance test in normal and non-insulin-dependent diabetic subjects. Eur J Clin Investig. 1998;28(4):329–33.CrossRef Ceriello A, Bortolotti N, Crescentini A, Motz E, Lizzio S, Russo A, et al. Antioxidant defences are reduced during the oral glucose tolerance test in normal and non-insulin-dependent diabetic subjects. Eur J Clin Investig. 1998;28(4):329–33.CrossRef
31.
Zurück zum Zitat Jain SK, Levine SN, Duett J, Hollier B. Reduced vitamin E and increased lipofuscin products in erythrocytes of diabetic rats. Diabetes. 1991;40(10):1241–4.CrossRefPubMed Jain SK, Levine SN, Duett J, Hollier B. Reduced vitamin E and increased lipofuscin products in erythrocytes of diabetic rats. Diabetes. 1991;40(10):1241–4.CrossRefPubMed
32.
Zurück zum Zitat Maritim AC, Sanders RA, Watkins JB. Diabetes, oxidative stress and antioxidants: a review. J Biochem Mol Toxicol. 2003;17(1):24–38.CrossRefPubMed Maritim AC, Sanders RA, Watkins JB. Diabetes, oxidative stress and antioxidants: a review. J Biochem Mol Toxicol. 2003;17(1):24–38.CrossRefPubMed
Metadaten
Titel
Lipid peroxidation, antioxidants, lipid profile, and HbA1c in diabetic patients
verfasst von
Chhunthang Thanpari
Roshan Takhelmayum
Naval Kishor Yadav
Mukesh Kumar Shrewastwa
Priyanka Thapa
Ravindra Kumar Mittal
Publikationsdatum
18.03.2015
Verlag
Springer India
Erschienen in
International Journal of Diabetes in Developing Countries / Ausgabe 2/2017
Print ISSN: 0973-3930
Elektronische ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-015-0356-6

Weitere Artikel der Ausgabe 2/2017

International Journal of Diabetes in Developing Countries 2/2017 Zur Ausgabe